시장보고서
상품코드
1270487

세계의 근이완제 시장 보고서(2023년)

Muscle Relaxant Drugs Global Market Report 2023

발행일: | 리서치사: The Business Research Company | 페이지 정보: 영문 250 Pages | 배송안내 : 2-10일 (영업일 기준)

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

근이완제 세계 시장은 2022년 41억 3,000만 달러에서 2023년에는 44억 5,000만 달러로, CAGR 7.8%로 성장할 것으로 예측됩니다. 러시아·우크라이나 전쟁은 적어도 단기적으로는 COVID-19 팬데믹으로부터의 세계 경제 회복 가능성을 혼란시켰습니다. 이 양국 간의 전쟁은 다수의 국가에 대한 경제 제재, 상품 가격 급등, 공급망 혼란으로 이어지고, 상품이나 서비스 전체에 인플레이션을 유발하여 세계의 많은 시장에 영향을 미쳤습니다. 근이완제 시장은 CAGR 6.8%로 2027년에 57억 9,000만 달러에 달할 것으로 예상됩니다.

2022년 근이완제 시장에서는 북미가 최대 지역이 되었습니다. 근이완제 보고서 대상 지역은 아시아태평양, 서유럽, 동유럽, 북미, 남미, 중동 및 아프리카입니다.

노인 인구의 증가는 향후 근이완제 시장의 성장을 촉진할 것으로 예상됩니다. 노인 인구는 65세 이상의 노인을 의미합니다. 근이완제는 근골격계 장애로 고통받을 가능성이 높은 노인 인구를 진정시키고 통증을 완화하는 데 사용됩니다. 예를 들어, 유엔 경제사회국의 2020년 9월 보고서에 따르면 65세 이상 인구는 2020년 9.3%에서 2050년 약 16.0%로 증가할 것으로 예상됩니다. 또한 세계보건기구(WHO)가 2021년 10월 발표한 팩트시트에 따르면, 2030년 전 세계 60세 이상 인구는 14억 명으로 2020년의 10억 명에서 증가할 것이라고 합니다. 따라서 노인 인구의 증가는 근이완제 시장의 성장을 주도하고 있습니다.

근이완제 시장에서는 제품 혁신이 향후 인기를 끌 주요 트렌드가 될 것으로 보입니다. 시장에서 활동하는 주요 기업들은 근이완제 제네릭, 동물용 근이완제, 유연하고 맞춤형 투여를 제공하는 의약품 등 특정 의료 용도를 위한 혁신적인 의약품을 개발하여 시장에서의 입지를 유지하고 있습니다. 예를 들어, 2022년 6월 미국의 종합 특수 의약품 회사인 Amneal Pharmaceuticals Inc.는 미국 식품의약국(FDA)으로부터 다발성 경화증 및 기타 척추 질환에 따른 경련 치료제로 승인받은 바클로펜 경구용 과립(5, 10, 20mg) 특수 제품 '리비스파(LYVISPAH)'를 출시하였습니다. LYVISPAH(R)는 다발성 경화증으로 인한 근육 경직, 경련 및 통증 치료에 사용되는 5mg, 10mg, 20mg의 과립형 단일 용량 분획으로, 유연한 맞춤형 투약이 가능한 LYVISPAHi를 출시했습니다. 빠르게 용해되는 향이 나는 과립은 정제를 삼키기 어려운 경련 환자들에게도 선택권을 제공합니다. 이 제품은 물의 유무에 관계없이 환자의 입에 직접 넣는 방법, 액체나 음식에 섞는 방법, 경장영양관을 통해 투여하는 방법 등 세 가지 방법으로 투여할 수 있습니다.

목차

제1장 주요 요약

제2장 근이완제 시장 특징

제3장 근이완제 시장 동향과 전략

제4장 근이완제 시장 - 거시경제 시나리오

  • 신종 코로나바이러스 감염증(COVID-19)이 근이완제 시장에 미치는 영향
  • 우크라이나·러시아 전쟁이 근이완제 시장에 미치는 영향
  • 고인플레이션이 근이완제 시장에 미치는 영향

제5장 근이완제 시장 규모와 성장

  • 세계의 근이완제 시장 실적, 2017-2022년
    • 시장 성장 촉진요인
    • 시장 성장 억제요인
  • 세계의 근이완제 시장 예측, 2022-2027F, 2032F
    • 시장 성장 촉진요인
    • 시장 성장 억제요인

제6장 근이완제 시장 세분화

  • 세계의 근이완제 시장, 약제 종류별 세분화, 실적 및 예측, 2017-2022, 2022-2027F, 2032F
  • 안면 근이완제
  • 골격근 이완제
  • 신경근 차단제
  • 세계의 근이완제 시장, 투여 경로별 세분화, 실적 및 예측, 2017-2022, 2022-2027F, 2032F
  • 경구
  • 주사제
  • 분사
  • 연고
  • 세계의 근이완제 시장, 제제별 세분화, 실적 및 예측, 2017-2022, 2022-2027F, 2032F
  • 시클로벤자프린
  • 카리소프로돌
  • 클로르족사존
  • 메타살론
  • 메토카바몰
  • 바클로펜
  • 티자니딘
  • 오르페나드린
  • 단트롤렌
  • 세계의 근이완제 시장, 최종사용자별 세분화, 실적 및 예측, 2017-2022, 2022-2027F, 2032F
  • 병원
  • 홈케어
  • 전문 클리닉
  • 기타 최종사용자

제7장 근이완제 시장 지역 및 국가 분석

  • 세계의 근이완제 시장, 지역별, 실적 및 예측, 2017-2022, 2022-2027F, 2032F
  • 세계의 근이완제 시장, 국가별, 실적 및 예측, 2017-2022, 2022-2027F, 2032F

제8장 아시아태평양 근이완제 시장

  • 아시아태평양 근이완제 시장 개요
  • 지역 정보, COVID-19증의 영향, 시장 정보, 배경 정보, 정부 대처, 규제, 규제기관, 주요 단체, 과세액, 법인세 구조, 투자, 주요 기업
  • 아시아태평양 근이완제 시장, 약제 유형별 세분화, 실적 및 예측, 2017-2022, 2022-2027F, 2032F
  • 아시아태평양 근이완제 시장, 최종사용자별 세분화, 실적 및 예측, 2017-2022, 2022-2027F, 2032F

제9장 중국의 근이완제 시장

  • 중국의 근이완제 시장 개요
  • 중국 당국 이완제시장, 약제 유형별 세분화, 실적 및 예측, 2017-2022, 2022-2027F, 2032F
  • 중국 당국 이완제시장, 최종사용자별 세분화, 실적 및 예측, 2017-2022, 2022-2027F, 2032F

제10장 인도의 근이완제 시장

  • 인도 근이완제 시장, 약제 유형별 세분화, 실적 및 예측, 2017-2022, 2022-2027F, 2032F
  • 인도 근이완제 시장, 최종사용자별 세분화, 실적 및 예측, 2017-2022, 2022-2027F, 2032F

제11장 일본의 근이완제 시장

  • 일본의 근이완제 시장, 약제 유형별 세분화, 실적 및 예측, 2017-2022, 2022-2027F, 2032F
  • 일본의 근이완제 시장, 최종사용자별 세분화, 실적 및 예측, 2017-2022, 2022-2027F, 2032F

제12장 호주의 근이완제 시장

  • 호주 근이완제 시장, 약제 유형별 세분화, 실적 및 예측, 2017-2022, 2022-2027F, 2032F
  • 호주 근이완제 시장, 최종사용자별 세분화, 실적 및 예측, 2017-2022, 2022-2027F, 2032F

제13장 인도네시아의 근이완제 시장

  • 인도네시아 근이완제 시장, 약제 유형별 세분화, 실적 및 예측, 2017-2022, 2022-2027F, 2032F
  • 인도네시아 근이완제 시장, 최종사용자별 세분화, 실적 및 예측, 2017-2022, 2022-2027F, 2032F

제14장 한국의 근이완제 시장

  • 한국 근이완제 시장, 약제 유형별 세분화, 실적 및 예측, 2017-2022, 2022-2027F, 2032F
  • 한국 근이완제 시장, 최종사용자별 세분화, 실적 및 예측, 2017-2022, 2022-2027F, 2032F

제15장 서유럽의 근이완제 시장

  • 서유럽의 근이완제 시장 개요
  • 서유럽 근이완제 시장, 약제 유형별 세분화, 실적 및 예측, 2017-2022, 2022-2027F, 2032F
  • 서유럽의 근이완제 시장, 최종사용자별 세분화, 실적 및 예측, 2017-2022, 2022-2027F, 2032F

제16장 영국의 근이완제 시장

  • 영국 근이완제 시장, 약제 유형별 세분화, 실적 및 예측, 2017-2022, 2022-2027F, 2032F
  • 영국 근이완제 시장, 최종사용자별 세분화, 실적 및 예측, 2017-2022, 2022-2027F, 2032F

제17장 독일의 근이완제 시장

  • 독일 근이완제 시장, 약제 유형별 세분화, 실적 및 예측, 2017-2022, 2022-2027F, 2032F
  • 독일 근이완제 시장, 최종사용자별 세분화, 실적 및 예측, 2017-2022, 2022-2027F, 2032F

제18장 프랑스의 근이완제 시장

  • 프랑스 근이완제 시장, 약제 유형별 세분화, 실적 및 예측, 2017-2022, 2022-2027F, 2032F
  • 프랑스 근이완제 시장, 최종사용자별 세분화, 실적 및 예측, 2017-2022, 2022-2027F, 2032F

제19장 동유럽의 근이완제 시장

  • 동유럽의 근이완제 시장 개요
  • 동유럽 근이완제 시장, 약제 유형별 세분화, 실적 및 예측, 2017-2022, 2022-2027F, 2032F
  • 동유럽 근이완제 시장, 최종사용자별 세분화, 실적 및 예측, 2017-2022, 2022-2027F, 2032F

제20장 러시아의 근이완제 시장

  • 러시아의 근이완제 시장, 약제 종류별 세분화, 실적 및 예측, 2017-2022, 2022-2027F, 2032F
  • 러시아 근이완제 시장, 최종사용자별 세분화, 실적 및 예측, 2017-2022, 2022-2027F, 2032F

제21장 북미의 근이완제 시장

  • 북미 근이완제 시장 개요
  • 북미 근이완제 시장, 약제 유형별 세분화, 실적 및 예측, 2017-2022, 2022-2027F, 2032F
  • 북미 근이완제 시장, 최종사용자별 세분화, 실적 및 예측, 2017-2022, 2022-2027F, 2032F

제22장 미국의 근이완제 시장

  • 미국의 근이완제 시장 개요
  • 미국 근이완제 시장, 약제 유형별 세분화, 실적 및 예측, 2017-2022, 2022-2027F, 2032F
  • 미국 근이완제 시장, 최종사용자별 세분화, 실적 및 예측, 2017-2022, 2022-2027F, 2032F

제23장 남미의 근이완제 시장

  • 남미 근이완제 시장 개요
  • 남미 근이완제 시장, 약제 유형별 세분화, 실적 및 예측, 2017-2022, 2022-2027F, 2032F
  • 남미 근이완제 시장, 최종사용자별 세분화, 실적 및 예측, 2017-2022, 2022-2027F, 2032F

제24장 브라질의 근이완제 시장

  • 브라질 근이완제 시장, 약제 유형별 세분화, 실적 및 예측, 2017-2022, 2022-2027F, 2032F
  • 브라질 근이완제 시장, 최종사용자별 세분화, 실적 및 예측, 2017-2022, 2022-2027F, 2032F

제25장 중동의 근이완제 시장

  • 중동의 근이완제 시장 개요
  • 중동 근이완제 시장, 약제 유형별 세분화, 실적 및 예측, 2017-2022, 2022-2027F, 2032F
  • 중동 근이완제 시장, 최종사용자별 세분화, 실적 및 예측, 2017-2022, 2022-2027F, 2032F

제26장 아프리카의 근이완제 시장

  • 아프리카의 근이완제 시장 개요
  • 아프리카 근이완제 시장, 약제 유형별 세분화, 실적 및 예측, 2017-2022, 2022-2027F, 2032F
  • 아프리카 근이완제 시장, 최종사용자별 세분화, 실적 및 예측, 2017-2022, 2022-2027F, 2032F

제27장 근이완제 시장 경쟁 상황과 기업 개요

  • 근이완제 시장 경쟁 상황
  • 근이완제 시장 기업 개요
    • Pfizer Inc.
    • Ipsen Pharma
    • Teijin Limited
    • Par Pharmaceutical
    • Orient Phaarma

제28장 근이완제 시장의 주요 인수합병

제29장 근이완제 시장 향후 전망과 가능성 분석

제30장 부록

KSM 23.05.19

“Muscle Relaxant Drugs Global Market Report 2023 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on muscle relaxant drugs market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for muscle relaxant drugs? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The muscle relaxant drugs market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

  • 1) By Drug Type: Facial Muscle Relaxant Drugs; Skeletal Muscle Relaxant Drugs; Neuromuscular Blocking Agents
  • 2) By Route of Administration: Oral; Injectable; Spray; Ointment
  • 3) By Formulation: Cyclobenzaprine; Carisoprodol; Chlorzoxazone; Metaxalone; Methocarbamol; Baclofen; Tizanidine; Orphenadrine; Dantrolene
  • 4) By End-User: Hospitals; Homecare; Speciality Clinics; Other End-Users
  • Companies Mentioned: Pfizer Inc.; Ipsen Pharma; Teijin Limited; Par Pharmaceutical; Orient Phaarma
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Major players in the muscle relaxant drugs market are Pfizer Inc., Ipsen Pharma, Teijin Limited, Par Pharmaceutical, Orient Phaarma, Sandoz International GmbH, Accord Healthcare, Amneal Pharmaceuticals LLC, Fresenius Kabi India Pvt. Ltd., Aurobindo Pharma, Mylan N.V., Hikma Pharmaceuticals PLC, Lupin, Akorn Incorporated, and Merck & Co. Inc.

The global muscle relaxant drugs market is expected to grow from $4.13 billion in 2022 to $4.45 billion in 2023 at a compound annual growth rate (CAGR) of 7.8%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The muscle relaxant drugs market is expected to reach $5.79 billion in 2027 at a CAGR of 6.8%.

The muscle relaxant drugs market consists of sales of antispasmodics, benzodiazepines and nonbenzodiazepines. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

Muscle relaxants are medications that are used to treat muscle spasms caused by neurological conditions. These are used for treating muscle pains.

North America was the largest region in the muscle relaxant drugs market in 2022. The regions covered in the muscle relaxant drugs report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The main drug types of muscle relaxant drugs are facial muscle relaxant drugs, skeletal muscle relaxant drugs and neuromuscular blocking agents. The facial muscle relaxant is a muscle relaxant used to treat facial spasms and cramps. The route of administration includes oral, injectable, spray, and ointment with various formulations such as cyclobenzaprine, carisoprodol, chlorzoxazone, metaxalone, methocarbamol, baclofen, tizanidine, orphenadrine, and dantrolene. The various end-users are hospitals, home care, specialty clinics and others.

The rising geriatric population is expected to propel the growth of the muscle relaxant drugs market going forward. The geriatric population refers to older adults 65 years and beyond. Muscle relaxant drugs are used for sedating and reducing the pain of the geriatric population who are more likely to suffer from musculoskeletal disorders. For instance, according to the United Nations Department of Economic and Social Affairs' September 2020 report, the population aged 65 and above is projected to rise from 9.3% in 2020 to around 16.0% in 2050. Furthermore, according to October 2021 published factsheet by World Health Organization, there will be 1.4 billion individuals over the age of 60 in the world by 2030, up from 1 billion in 2020. Therefore, the rising geriatric population is driving the growth of the muscle relaxant drugs market.

Product innovations are the key trend gaining popularity in the muscle relaxant drugs market going forward. Major companies operating in the market are developing innovative drugs for specific medical applications such as generic versions of muscle relaxant drugs, muscle relaxants for animals, drugs that provide flexible, customized dosing, and others to sustain their position in the market. For instance, in June 2022, Amneal Pharmaceuticals Inc., a US-based integrated specialty pharmaceutical company, launched LYVISPAH®, a baclofen oral granule (5, 10, and 20 mg) specialty product approved by the US Food and Drug Administration for the treatment of spasticity associated with multiple sclerosis and other spinal cord disorders. LYVISPAHi offers flexible, customized dosing with 5mg, 10mg, and 20mg single-dose packets of granules that are used in treating muscle stiffness, spasms, and pain from multiple sclerosis. The rapidly dissolving flavored granules offer an alternative for patients with spasticity who also have difficulty swallowing pills. The product can be administered in three ways: directly into the patient's mouth with or without water, mixed with liquids or foods, or through an enteral feeding tube.

In 2020, AbbVie, a US-based global biopharmaceutical company acquired Allergan plc for an undisclosed amount. The deal considerably broadens and diversifies AbbVie's income stream and strengthens the company's already-established leadership positions in immunology with Humira®, hematologic oncology with Imbruvica®, and Rinvoq®. Allergan plc US-based company that manufactures and sell muscle relaxant drugs.

The countries covered in the muscle relaxant drugs market report are: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The muscle relaxant drugs market research report is one of a series of new reports from The Business Research Company that provides muscle relaxant drugs market statistics, including the muscle relaxant drugs industry's global market size, regional shares, competitors with a muscle relaxant drugs market share, detailed muscle relaxant drugs market segments, market trends and opportunities, and any further data you may need to thrive in the muscle relaxant drugs industry. This muscle relaxant drugs market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Table of Contents

1. Executive Summary

2. Muscle Relaxant Drugs Market Characteristics

3. Muscle Relaxant Drugs Market Trends And Strategies

4. Muscle Relaxant Drugs Market - Macro Economic Scenario

  • 4.1. COVID-19 Impact On Muscle Relaxant Drugs Market
  • 4.2. Ukraine-Russia War Impact On Muscle Relaxant Drugs Market
  • 4.3. Impact Of High Inflation On Muscle Relaxant Drugs Market

5. Muscle Relaxant Drugs Market Size And Growth

  • 5.1. Global Muscle Relaxant Drugs Historic Market, 2017-2022, $ Billion
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints On The Market
  • 5.2. Global Muscle Relaxant Drugs Forecast Market, 2022-2027F, 2032F, $ Billion
    • 5.2.1. Drivers Of The Market
    • 5.2.2. Restraints On the Market

6. Muscle Relaxant Drugs Market Segmentation

  • 6.1. Global Muscle Relaxant Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Facial Muscle Relaxant Drugs
  • Skeletal Muscle Relaxant Drugs
  • Neuromuscular Blocking Agents
  • 6.2. Global Muscle Relaxant Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Oral
  • Injectable
  • Spray
  • Ointment
  • 6.3. Global Muscle Relaxant Drugs Market, Segmentation By Formulation, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Cyclobenzaprine
  • Carisoprodol
  • Chlorzoxazone
  • Metaxalone
  • Methocarbamol
  • Baclofen
  • Tizanidine
  • Orphenadrine
  • Dantrolene
  • 6.4. Global Muscle Relaxant Drugs Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Hospitals
  • Homecare
  • Speciality Clinics
  • Other End-Users

7. Muscle Relaxant Drugs Market Regional And Country Analysis

  • 7.1. Global Muscle Relaxant Drugs Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 7.2. Global Muscle Relaxant Drugs Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

8. Asia-Pacific Muscle Relaxant Drugs Market

  • 8.1. Asia-Pacific Muscle Relaxant Drugs Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Muscle Relaxant Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 8.3. Asia-Pacific Muscle Relaxant Drugs Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

9. China Muscle Relaxant Drugs Market

  • 9.1. China Muscle Relaxant Drugs Market Overview
  • 9.2. China Muscle Relaxant Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion
  • 9.3. China Muscle Relaxant Drugs Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion

10. India Muscle Relaxant Drugs Market

  • 10.1. India Muscle Relaxant Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 10.2. India Muscle Relaxant Drugs Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

11. Japan Muscle Relaxant Drugs Market

  • 11.1. Japan Muscle Relaxant Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 11.2. Japan Muscle Relaxant Drugs Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

12. Australia Muscle Relaxant Drugs Market

  • 12.1. Australia Muscle Relaxant Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 12.2. Australia Muscle Relaxant Drugs Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

13. Indonesia Muscle Relaxant Drugs Market

  • 13.1. Indonesia Muscle Relaxant Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 13.2. Indonesia Muscle Relaxant Drugs Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

14. South Korea Muscle Relaxant Drugs Market

  • 14.1. South Korea Muscle Relaxant Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 14.2. South Korea Muscle Relaxant Drugs Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

15. Western Europe Muscle Relaxant Drugs Market

  • 15.1. Western Europe Muscle Relaxant Drugs Market Overview
  • 15.2. Western Europe Muscle Relaxant Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 15.3. Western Europe Muscle Relaxant Drugs Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

16. UK Muscle Relaxant Drugs Market

  • 16.1. UK Muscle Relaxant Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 16.2. UK Muscle Relaxant Drugs Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

17. Germany Muscle Relaxant Drugs Market

  • 17.1. Germany Muscle Relaxant Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 17.2. Germany Muscle Relaxant Drugs Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

18. France Muscle Relaxant Drugs Market

  • 18.1. France Muscle Relaxant Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 18.2. France Muscle Relaxant Drugs Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

19. Eastern Europe Muscle Relaxant Drugs Market

  • 19.1. Eastern Europe Muscle Relaxant Drugs Market Overview
  • 19.2. Eastern Europe Muscle Relaxant Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 19.3. Eastern Europe Muscle Relaxant Drugs Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

20. Russia Muscle Relaxant Drugs Market

  • 20.1. Russia Muscle Relaxant Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 20.2. Russia Muscle Relaxant Drugs Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

21. North America Muscle Relaxant Drugs Market

  • 21.1. North America Muscle Relaxant Drugs Market Overview
  • 21.2. North America Muscle Relaxant Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 21.3. North America Muscle Relaxant Drugs Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

22. USA Muscle Relaxant Drugs Market

  • 22.1. USA Muscle Relaxant Drugs Market Overview
  • 22.2. USA Muscle Relaxant Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 22.3. USA Muscle Relaxant Drugs Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

23. South America Muscle Relaxant Drugs Market

  • 23.1. South America Muscle Relaxant Drugs Market Overview
  • 23.2. South America Muscle Relaxant Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 23.3. South America Muscle Relaxant Drugs Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

24. Brazil Muscle Relaxant Drugs Market

  • 24.1. Brazil Muscle Relaxant Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 24.2. Brazil Muscle Relaxant Drugs Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

25. Middle East Muscle Relaxant Drugs Market

  • 25.1. Middle East Muscle Relaxant Drugs Market Overview
  • 25.2. Middle East Muscle Relaxant Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 25.3. Middle East Muscle Relaxant Drugs Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

26. Africa Muscle Relaxant Drugs Market

  • 26.1. Africa Muscle Relaxant Drugs Market Overview
  • 26.2. Africa Muscle Relaxant Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 26.3. Africa Muscle Relaxant Drugs Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

27. Muscle Relaxant Drugs Market Competitive Landscape And Company Profiles

  • 27.1. Muscle Relaxant Drugs Market Competitive Landscape
  • 27.2. Muscle Relaxant Drugs Market Company Profiles
    • 27.2.1. Pfizer Inc.
      • 27.2.1.1. Overview
      • 27.2.1.2. Products and Services
      • 27.2.1.3. Strategy
      • 27.2.1.4. Financial Performance
    • 27.2.2. Ipsen Pharma
      • 27.2.2.1. Overview
      • 27.2.2.2. Products and Services
      • 27.2.2.3. Strategy
      • 27.2.2.4. Financial Performance
    • 27.2.3. Teijin Limited
      • 27.2.3.1. Overview
      • 27.2.3.2. Products and Services
      • 27.2.3.3. Strategy
      • 27.2.3.4. Financial Performance
    • 27.2.4. Par Pharmaceutical
      • 27.2.4.1. Overview
      • 27.2.4.2. Products and Services
      • 27.2.4.3. Strategy
      • 27.2.4.4. Financial Performance
    • 27.2.5. Orient Phaarma
      • 27.2.5.1. Overview
      • 27.2.5.2. Products and Services
      • 27.2.5.3. Strategy
      • 27.2.5.4. Financial Performance

28. Key Mergers And Acquisitions In The Muscle Relaxant Drugs Market

29. Muscle Relaxant Drugs Market Future Outlook and Potential Analysis

30. Appendix

  • 30.1. Abbreviations
  • 30.2. Currencies
  • 30.3. Historic And Forecast Inflation Rates
  • 30.4. Research Inquiries
  • 30.5. The Business Research Company
  • 30.6. Copyright And Disclaimer
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제